Corthera is engaged in acquiring, developing and commercializing therapies for illnesses in the acute care setting.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: San Carlos
State: California
Zip:
Country: United States
Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera&s;s lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2004 | Series B | 3 | $15M |
Domain Associates Johnson &a; Johnson Development Corporation Kleiner Perkins Domain Associates Johnson &a; Johnson Development Corporation Kleiner Perkins |
7/2003 | Series A | 2 | $2.1M |
Kleiner Perkins Domain Associates Kleiner Perkins Domain Associates |
12/2007 | Series C | 3 | $23M |
Caxton Advantage Life Sciences Fund Domain Associates Kleiner Perkins Caxton Advantage Life Sciences Fund Domain Associates Kleiner Perkins |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|